fashion -WSS

fashion

author：focus 2025-08-26 01:32:45 - browse：28719

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Bird flu outbreak in cows is latest avian flu curveball

Wikipedia

WSS

Apple Watch's A

Making AI in medicine accessible to smaller, and rural hospitals

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Elisabeth Bik tackles the widespread issue of research misconduct

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

hotspot

fashion

leisure time

In age of alternative facts, a scholarly course on calling out crap

Brain worms: The science behind RFK Jr.'s parasitic infection

Psychedelics group wrestles with new pharma identity

Medicare says breakthrough device reimbursement rule to come by summer

Wildfire smoke exposes gaps in outdoor worker protections

Ohio train derailment: Experts on toxic chemical risks

Psychedelics group wrestles with new pharma identity

Study: People of West African ancestry at greater risk of cardiac amyloidosis

BioMarin wins approval for gene therapy to treat hemophilia A

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

entertainment

CDC wastewater surveillance dashboard to track bird flu hotspots

CDC wastewater surveillance dashboard to track bird flu hotspots

H5N1 communication has been strictly for the birds

H5N1 bird flu: what we're starting to learn about infection in cows

Bird flu outbreak in cows is latest avian flu curveball

CDC wastewater surveillance dashboard to track bird flu hotspots

focus

Wikipedia

focus

Wikipedia